The company
Veradermics, Incorporated
MANE · NYSE
We hold no 150-day reading for MANE yet: it needs about 200 sessions of history. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- not in the set
- Weeks in an uptrend
- —
- Industry in uptrend
- 18% -12 in 4 wk
- Insider buys, 12 months
- $118.2M
- Insider sales, 12 months
- $206.2M
- Officials’ trades on record
- 0
- Institutions holding
- 161 (+83)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Montanova Capital, LlcDirector | sold | 690,601at $107.25 | 19 Aug 2026filed 21 Aug 2026 |
| Montanova Capital, LlcDirector | sold | 59,399at $107.25 | 19 Aug 2026filed 21 Aug 2026 |
| Reid Alexander WaldmanChief Executive Officer | sold | 11,527at $106.72 | 17 Aug 2026filed 18 Aug 2026 |
| Reid Alexander WaldmanChief Executive Officer | sold | 25,234at $107.53 | 17 Aug 2026filed 18 Aug 2026 |
| Reid Alexander WaldmanChief Executive Officer | sold | 27,490at $108.45 | 17 Aug 2026filed 18 Aug 2026 |
| Reid Alexander WaldmanChief Executive Officer | sold | 3,000at $109.38 | 17 Aug 2026filed 18 Aug 2026 |
| Reid Alexander WaldmanChief Executive Officer | sold | 249at $111.28 | 17 Aug 2026filed 18 Aug 2026 |
| Timothy August DursoChief Technical Officer | sold | 7,918at $106.71 | 17 Aug 2026filed 18 Aug 2026 |
| Timothy August DursoChief Technical Officer | sold | 16,306at $107.52 | 17 Aug 2026filed 18 Aug 2026 |
| Timothy August DursoChief Technical Officer | sold | 16,767at $108.38 | 17 Aug 2026filed 18 Aug 2026 |
| Timothy August DursoChief Technical Officer | sold | 2,348at $109.34 | 17 Aug 2026filed 18 Aug 2026 |
| Timothy August DursoChief Technical Officer | sold | 161at $111.28 | 17 Aug 2026filed 18 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| MONTANOVA CAPITAL, LLCunchanged · filed 14 Aug 2026 | 4,168,970$512.5M | 00.0% |
| FMR LLCadded · filed 13 Aug 2026 | 3,204,981$394.0M | +1,412,072+78.8% |
| SR One Capital Management, LPunchanged · filed 12 Aug 2026 | 2,401,868$295.3M | 00.0% |
| Deep Track Capital, LPadded · filed 14 Aug 2026 | 2,000,000$245.9M | +1,500,000+300.0% |
| CITADEL ADVISORS LLCadded · filed 14 Aug 2026 | 1,877,775$230.9M | +52,103+2.9% |
| Siren, L.L.C.added · filed 13 Aug 2026 | 1,655,374$203.5M | +150,000+10.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 1,593,791$195.9M | +1,311,180+464.0% |
| VIKING GLOBAL INVESTORS LPreduced · filed 14 Aug 2026 | 1,561,494$192.0M | -129,061−7.6% |
| JPMORGAN CHASE & COnew · filed 12 Aug 2026 | 1,165,584$144.2M | +1,165,584 |
| Aberdeen Group plcadded · filed 31 Jul 2026 | 1,096,642$134.8M | +41,982+4.0% |
News
No headline names it lately.
Everyone who traded it
Same industry
No other stock in its industry this week.
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.